Placenta
Volume 28 , Pages S51-S56 , April 2007

How Does the Maternal Immune System Contribute to the Development of Pre-eclampsia?

,Accepted 27 November 2006.

References 

  1. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006;27:939–958
  2. Redman CW. Immunology of preeclampsia. Semin Perinatol. 1991;15:257–262
  3. Walker JJ. Pre-eclampsia. Lancet. 2000;356:1260–1265
  4. Robertson WB, Brosens I, Pijnenborg R, De Wolf F. The making of the placental bed. Eur J Obstet Gynecol Reprod Biol. 1984;18:255–266
  5. Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2004;18:383–396
  6. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2:656–663
  7. MacGillivray I. Some observations on the incidence of pre-eclampsia. J Obstet Gynaecol Br Emp. 1958;65:536–539
  8. Trogstad L. The paternal role in pre-eclampsia. In:  Critchley H,  MacLean A,  Poston L,  Walker J editor. Pre-eclampsia. RCOG Press; 2003;p. 208–224
  9. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–799
  10. Mostello D, Catlin TK, Roman L, Holcomb WL, Leet T. Preeclampsia in the parous woman: who is at risk?. Am J Obstet Gynecol. 2002;187:425–429
  11. Hjartardottir S, Leifson BG, Geirsson RT, Steinthorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol. 2006;194:916–920
  12. Dekker G, Robillard PY. The birth interval hypothesis—does it really indicate the end of the primipaternity hypothesis. J Reprod Immunol. 2003;59:245–251
  13. Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology. 1996;7:240–244
  14. Li DK, Wi, S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol 151;57–62.
  15. Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod. 1999;14:2268–2273
  16. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 2001;344:867–872
  17. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ. 2005;331:877
  18. Alderman BW, Sperling RS, Daling JR. An epidemiological study of the immunogenetic aetiology of pre-eclampsia. Br Med J (Clin Res Ed). 1986;292:372–374
  19. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol. 2005;106:156–161
  20. Medawar P. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol. 1953;7:320–328
  21. Parham P. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol Lett. 2004;29:11–13
  22. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet. 2006;7:277–300
  23. Hiby SE, Walker J, O'Shaughnessy KM, Redman CWG, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004;200:957–965
  24. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5:201–214
  25. Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab. 2001;86:1823–1834
  26. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med. 2003;198:1201–1212
  27. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol. 2006;80:572–580
  28. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes in the human fetal-maternal interface. Nat Med. 2006;12:1065–1074
  29. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ. 1998;316:1343–1347

PII: S0143-4004(06)00278-5

doi: 10.1016/j.placenta.2006.11.008

Placenta
Volume 28 , Pages S51-S56 , April 2007

Article Tools

* Image Usage & Resolution